Salkind Gene (CIK 0001592481)

Latest company ownership

Shares held
7,519,730
Last filed at
Aug 22, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
UPXI - UPEXI, INC.
Role: Director
Shares held
218,750
Last filed at
Nov 21, 2025
Confidence Score
98.2
2025Q4
Confidence Score History
2022Q1 2025Q4
Shares held
32,684
Last filed at
Jan 9, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 20, 2025 Nov 21, 2025 UPEXI, INC. Director Buy 95.0 +50,000 29.63% ✗ $127.5K
Nov 17, 2025 Nov 18, 2025 UPEXI, INC. Director Buy 97.5 +200,000 37.16% ✗ $546K
Jul 11, 2025 Jul 30, 2025 UPEXI, INC. Director Buy 95.0 +220,243 60.32% ✗ $100K
Apr 17, 2025 Apr 25, 2025 UPEXI, INC. Director Buy 97.5 +241,229 194.70% ✗ $550K
Jan 5, 2024 Jan 9, 2024 Coeptis Therapeutics Holdings, Inc. Director Buy 82.5 +11,600 3.80% ✗ $8K
Aug 25, 2023 Aug 30, 2023 Coeptis Therapeutics Holdings, Inc. Director Buy 91.3 +32,644 13.05% ✗ $30.1K
Mar 30, 2022 Apr 1, 2022 UPEXI, INC. Director Buy 92.5 +125,000 5.31% ✗ $500K
Sep 13, 2019 Jan 21, 2020 Mobiquity Technologies, Inc. Director Buy 100.0 +175,000,000 191.64% ✗ $3.2M
Sep 13, 2019 Sep 19, 2019 Mobiquity Technologies, Inc. Director Buy 100.0 +175,000,000 191.64% ✗ $3.2M